GCP
BEAT

GSA Capital Partners’s BioTelemetry, Inc. BEAT Stock Holding History

GSA Capital Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,399
Closed -$338K – 1900
2019
Q1 		$338K Buy
+5,399
New +$371K 0.03% 925
2018
Q1 		– Sell
-33,827
Closed -$1.01M – 1999
2017
Q4 		$1.01M Buy
33,827
+1,692
+5% +$49K 0.06% 592
2017
Q3 		$1.06M Sell
32,135
-1,534
-5% -$53.1K 0.07% 490
2017
Q2 		$1.13M Sell
33,669
-80,459
-70% -$2.4M 0.07% 478
2017
Q1 		$3.3M Sell
114,128
-9,400
-8% -$233K 0.18% 82
2016
Q4 		$2.76M Sell
123,528
-30,760
-20% -$601K 0.17% 110
2016
Q3 		$2.87M Sell
154,288
-11,540
-7% -$218K 0.15% 116
2016
Q2 		$2.7M Buy
165,828
+75,227
+83% +$1.11M 0.15% 130
2016
Q1 		$1.06M Buy
90,601
+72,380
+397% +$809K 0.07% 504
2015
Q4 		$213K Sell
18,221
-75,807
-81% -$959K 0.01% 1625
2015
Q3 		$1.15M Sell
94,028
-7,900
-8% -$101K 0.06% 547
2015
Q2 		$961K Sell
101,928
-11,441
-10% -$106K 0.04% 938
2015
Q1 		$1M Buy
113,369
+31,214
+38% +$315K 0.04% 857
2014
Q4 		$824K Buy
82,155
+62,310
+314% +$534K 0.06% 594
2014
Q3 		$133K Sell
19,845
-95,100
-83% -$667K 0.01% 1595
2014
Q2 		$824K Buy
114,945
+46,200
+67% +$368K 0.04% 790
2014
Q1 		$694K Sell
68,745
-10,200
-13% -$93.9K 0.05% 552
2013
Q4 		$627K Sell
78,945
-16,100
-17% -$150K 0.05% 665
2013
Q3 		$942K Buy
95,045
+16,900
+22% +$133K 0.07% 382
2013
Q2 		$461K Buy
+78,145
New +$263K 0.05% 594

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSA Capital Partners's BEAT Position: Q2 2019 in Review

GSA Capital Partners sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 5,399 shares — an estimated $338K sold.

GSA Capital Partners first reported a position in BEAT in Q2 2013 and held it in 20 quarters. The position peaked at $3.3M in Q1 2017. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • GSA Capital Partners reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • GSA Capital Partners sold 5,399 BioTelemetry, Inc. shares in Q2 2019, an estimated $338K.
  • GSA Capital Partners first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 20 quarters.
  • GSA Capital Partners's BioTelemetry, Inc. position peaked at $3.3M in Q1 2017.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on GSA Capital Partners's 13F filing for Q2 2019, filed 6 Aug 2019.